Volume 2(Supplement 1):63-66

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
How I treat HHV8/KSHV-related diseases in posttransplant patients by Giovanni Riva, Mario Luppi, Patrizia Barozzi, Fabio Forghieri, and Leonardo Potenza.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation by Surbhi Shah, Faye L. Norby, Yvonne.
Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative.
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts by Boglarka Gyurkocza,
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis by Paolo Prandoni,
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
How I treat elderly patients with myeloma
Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,
An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim.
Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.
Genetic sequence analysis of inherited bleeding diseases
Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
by John C. Wood, Pinggao Zhang, Hugh Y
Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients by Oluwagbemiga O. Ayoola, Rahman A.
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma by Mohammed A. Aljama, M. Hasib Sidiqi, Arjun.
Patients’ priorities in selecting chronic lymphocytic leukemia treatments by Carol Mansfield, Anthony Masaquel, Jessie Sutphin, Elisa Weiss, Meghan Gutierrez,
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Laboratory capacity-building initiative to assess folate status in women of reproductive age from Haryana, India: the collaborative experience of local.
Activity of eltrombopag in severe aplastic anemia
Immunotherapy for acute lymphoblastic leukemia: from famine to feast
Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma by Young Ae Kim, Ja Min Byun, Keeho Park, Gi Hwan Bae, Dukhyoung.
Where there’s a will, there’s a way: establishing hematopoietic stem cell transplantation in Myanmar by Aye Aye Gyi, Rai Mra, Htun Lwin Nyein, Thida Aung,
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study by C. Madsen, M. R. Clausen, T. L. Plesner,
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.
Volume 2(Supplement 1):26-29
Volume 2(Supplement 1):8-10
by Kaiwen Chen, Matthew P. Cheng, Sarah P
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
Volume 2(Supplement 1):1-3
Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?  James J. Farrell, MD  Gastrointestinal Endoscopy 
Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.
Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.
by Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F
Platelets and hemostasis: a new perspective on an old subject
Plasma biomarker concentrations between study groups.
by Christine L. Kempton, and Amanda B. Payne
A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand by Andreas Greinacher, Kerstin.
Volume 2(Supplement 1):46-49
Ontogeny of platelet function
Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma by Nidhi Tandon, Surbhi Sidana, S. Vincent Rajkumar,
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis by Samuel Yamshon,
by Elizabeth C. Neil, and Lisa M. DeAngelis
Volume 2(Supplement 1):14-16
by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry by Donald M. Arnold, Ishac Nazy, Rumi.
Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma by Tomer M. Mark, Peter A. Forsberg, Adriana.
Volume 2(Supplement 1):39-41
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis by Rasha Khatib, Maja Ludwikowska, Daniel.
by David Deambrosis, Su Han Lum, Ryan M
The journey of stem cell transplantation in Bangladesh: a hike to the state of the art with collaboration between DMCH and MGH by Mafruha Akter, Mohiuddin.
by Matthew S. Painschab, Kate D
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor.
Resistance mechanism for ibrutinib in marginal zone lymphoma
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera by Nikolai A. Podoltsev, Mengxin.
Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations by Ami B. Patel, Erin M. Pettijohn,
by Deogratias Ruhangaza, Andrew G. Evans, and Elizabeth A. Morgan
Patient Tregs express normal levels of suppression.
A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.
Volume 2(Supplement 1):4-7
Cold agglutinin disease
New concepts for anticoagulant therapy in persons with hemophilia
Presentation transcript:

Volume 2(Supplement 1):63-66 The “Golden Hour”: a capacity-building initiative to decrease life-threating complications related to neutropenic fever in patients with hematologic malignancies in low- and middle-income countries by Mario Ornelas-Sánchez, Laura Nuño-Vázquez, Adriana Loera-Reyna, Dara Torres-Reyes, Rebeca Rivera-Gómez, Alicia Sánchez, Mitzy Romano, Miriam González, Miguela A. Caniza, and Paula Aristizabal BloodAdv Volume 2(Supplement 1):63-66 November 30, 2018 © 2018 by The American Society of Hematology

The Golden box showing all of the supplies and medications needed for each NF event. Mario Ornelas-Sánchez et al. Blood Adv 2018;2:63-66 © 2018 by The American Society of Hematology

Nursing staff at an 8-hour training workshop that included pre- and posttest assessments. Mario Ornelas-Sánchez et al. Blood Adv 2018;2:63-66 © 2018 by The American Society of Hematology

A training workshop being conducted for parents of newly diagnosed patients on the basic concepts of NF. A training workshop being conducted for parents of newly diagnosed patients on the basic concepts of NF. Mario Ornelas-Sánchez et al. Blood Adv 2018;2:63-66 © 2018 by The American Society of Hematology

A refresher workshop was held for nursing and medical staff. Mario Ornelas-Sánchez et al. Blood Adv 2018;2:63-66 © 2018 by The American Society of Hematology